Canada · Delayed Price · Currency is CAD BioNxt Solutions Statistics
Total Valuation
CSE:BNXT has a market cap or net worth of CAD 57.57 million. The enterprise value is 65.43 million.
| Market Cap | 57.57M |
| Enterprise Value | 65.43M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:BNXT has 122.49 million shares outstanding. The number of shares has increased by 6.00% in one year.
| Current Share Class | 122.49M |
| Shares Outstanding | 122.49M |
| Shares Change (YoY) | +6.00% |
| Shares Change (QoQ) | +1.35% |
| Owned by Insiders (%) | 5.96% |
| Owned by Institutions (%) | n/a |
| Float | 115.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3,638.49 |
| PB Ratio | -6.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.59 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -338.54% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 194.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 20 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -89,790 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.50% in the last 52 weeks. The beta is 1.18, so CSE:BNXT's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +17.50% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 33.76 |
| Average Volume (20 Days) | 73,522 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:BNXT had revenue of CAD 15,822 and -6.18 million in losses. Loss per share was -0.05.
| Revenue | 15,822 |
| Gross Profit | 15,822 |
| Operating Income | -5.26M |
| Pretax Income | -6.27M |
| Net Income | -6.18M |
| EBITDA | -5.23M |
| EBIT | -5.26M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 468,758 in cash and 8.33 million in debt, with a net cash position of -7.86 million or -0.06 per share.
| Cash & Cash Equivalents | 468,758 |
| Total Debt | 8.33M |
| Net Cash | -7.86M |
| Net Cash Per Share | -0.06 |
| Equity (Book Value) | -8.31M |
| Book Value Per Share | -0.07 |
| Working Capital | -3.06M |
Cash Flow
| Operating Cash Flow | -5.18M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -33,235.48% |
| Pretax Margin | -39,601.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:BNXT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.00% |
| Shareholder Yield | -6.00% |
| Earnings Yield | -10.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:BNXT has an Altman Z-Score of -92.7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -92.7 |
| Piotroski F-Score | 2 |